T. Rowe Price Associates »

Sionna Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $30M 756k 40.12
2025-12-31 $34M 831k 41.14
2025-09-30 $19M 638k 29.41
2025-06-30 $15M 861k 17.35
2025-03-31 $10M 996k 10.46

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
OrbiMed Advisors
Viking Global Investors
Atlas Venture Life Science Advisors
Enavate Sciences GP
Jennison Associates
BlackRock
Citadel Advisors
Vanguard Capital Management
Deerfield Management Company
T. Rowe Price Associates
State Street Corporation
Perceptive Advisors
Eventide Asset Management

View all funds holding Sionna Therapeutics